Evobrutinib matched Placebo

DRUG2 trials

Sponsors

EMD Serono Research & Development Institute, Inc.

Conditions

Relapsing-remitting Multiple Sclerosis

Phase 3

Study of Evobrutinib in Participants With RMS

TerminatedNCT04032171

EMD Serono Research & Development Institute, Inc.Relapsing-remitting Multiple Sclerosis

Start: 2019-09-10End: 2020-05-20Updated: 2021-08-05

Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)

TerminatedNCT04032158

EMD Serono Research & Development Institute, Inc.Relapsing-remitting Multiple Sclerosis

Start: 2019-08-26End: 2020-04-16Updated: 2021-08-05